中文 | English
Return
Total: 16 , 1/2
Show Home Prev Next End page: GO
Author:( Chaoqun HONG)

1.Expression and clinical significance of C1orf63 in breast cancer

Xuyuan LI ; Chaoqun HONG

Journal of International Oncology 2017;44(6):420-422

2.Tumor suppressor 1 of lung cancer in tumor genesis and development

Jiongyu CHEN ; Chaoqun HONG

Journal of International Oncology 2010;37(4):249-251

3.Esophageal cancer related gene 4 in tumor

Chaoqun HONG ; Yanjie YOU ; Jihong HUANG

Journal of International Oncology 2012;(11):806-808

4.Amplified in breast cancer 1 in tumorigenesis

Xiao WU ; Chaoqun HONG ; Mingyao WU

Journal of International Oncology 2012;39(2):99-101

5.Expression of C2orf40 protein and its clinical significance in human nasopharyngeal carcinoma

Lin PENG ; Yiteng HUANG ; Jiongyu CHEN ; Chaoqun HONG ; Xiao WU

Journal of International Oncology 2017;44(6):406-410

6.Inhibitory effects of arsenic trioxide in combination with aspirin on the angiogenesis of human gastric carcinoma xenografts in nude mice

Jing QIU ; Yongping WU ; Chaoqun WANG ; Hong LIU

Chinese Journal of Tissue Engineering Research 2007;0(33):-

7.Green Synthesis of Fluorescent Carbon Quantum Dots for Detection of Hg2+

Yue XU ; Chunjing TANG ; Hong HUANG ; Chaoqun SUN ; Yakun ZHANG ; Qunfeng YE ; Aijun WANG

Chinese Journal of Analytical Chemistry 2014;(9):1252-1258

9.Expression and clinical significance of amplified in breast cancer 1 and epithelial cadherin in ovarian carcinoma tissues

Xiao WU ; Yanjie YOU ; Chaoqun HONG ; Jiongyu CHEN ; Yixuan ZHUANG ; Mingyao WU

Chinese Journal of Postgraduates of Medicine 2012;35(15):1-5

10.Establishment of a cisplatin-induced human nasopharyngeal carcinoma drug-resistant cell line and its biological characteristics.

Wen LIN ; Derui LI ; Yingcheng LIN ; Caiwen DU ; Jiongyu CHEN ; Chaoqun HONG

Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2008;22(21):992-997

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 16 , 1/2 Show Home Prev Next End page: GO